Category: Life Sciences
Global Life Sciences
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Plant Cell Culture Equipment
... reach US$2.6 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$784.8 ... Read More
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Orphan Drugs
... at a CAGR of 11.9% over the analysis period 2023-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$286.3 Billion by the end of ... Read More
-
Compression Therapy
... at a CAGR of 6.5% over the analysis period 2023-2030. Varicose Vein Treatment Application, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.5 Billion by the ... Read More
-
Pesticide Inert Ingredients
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.3 Billion by the ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
-
Endobronchial Ultrasound Biopsy Devices
... reach US$925.2 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Transbronchial Aspiration Needles, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and ... Read More
-
Facial Injectables
... at a CAGR of 6.9% over the analysis period 2023-2030. Botulinum Toxin Type A, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$16.0 Billion by the ... Read More
-
Microwave Ablation
... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More
-
Sodium Alginate
... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More
-
Venturi Masks
... at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Surgical Cameras
... at a CAGR of 9.0% over the analysis period 2023-2030. HD & Full HD Resolution Cameras, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$4.3 Billion ... Read More
-
Surgical Lights
... at a CAGR of 5.1% over the analysis period 2023-2030. LED Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Urinary Drainage Bags
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Leg Bags, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.8 Billion by ... Read More
-
Molecular Breeding
... at a CAGR of 17.5% over the analysis period 2023-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$11.7 Billion by the ... Read More
-
Soft Tissue Repair
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Fixation Products, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.6 Billion by ... Read More
-
Urgent Care Apps
... by 2030, growing at a CAGR of 36.0% over the analysis period 2023-2030. Post-Hospital App, one of the segments analyzed in the report, is expected to record a 34.2% CAGR and reach US$13.6 Billion by ... Read More
-
Diabetic Shoes
... at a CAGR of 8.1% over the analysis period 2023-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... Kits and Analytical Instruments estimated at US$79.0 Billion in the year 2023, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Biochips & Microarrays, one ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Natural Antioxidants
... at a CAGR of 5.9% over the analysis period 2023-2030. Vitamin C, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Acne Drugs
... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
Research Assistance
